TipRanks
Actinium Pharmaceuticals (DE:7AY1)
FRANKFURT:7AY1
Germany Market

Actinium Pharmaceuticals (7AY1) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
2Neutral
11Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Actinium Pharmaceuticals’s (7AY1) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Actinium Pharmaceuticals is a Buy.
Actinium Pharmaceuticals’s (7AY1) 20-Day exponential moving average is 0.99, while Actinium Pharmaceuticals’s (7AY1) share price is €0.86, making it a Sell.
Actinium Pharmaceuticals’s (7AY1) 50-Day exponential moving average is 0.94, while Actinium Pharmaceuticals’s (7AY1) share price is €0.86, making it a Sell.

Actinium Pharmaceuticals (7AY1) Pivot Points

Oct 12, 2026, 05:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.94
0.94
0.94
0.94
0.94
0.94
0.94
Fibonacci
0.94
0.94
0.94
0.94
0.94
0.94
0.94
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Actinium Pharmaceuticals (7AY1) Moving Averages

Oct 12, 2026, 05:13 AM
Period
Simple
Exponential
MA5
0.98Sell
0.97Sell
MA10
0.99Sell
0.98Sell
MA20
1.02Sell
0.99Sell
MA50
0.91Buy
0.94Sell
MA100
0.88Buy
0.93Buy
MA200
0.94Sell
0.98Sell
Actinium Pharmaceuticals’s (7AY1) 10-Day exponential moving average is 0.98, while Actinium Pharmaceuticals’s (7AY1) share price is €0.86, making it a Sell.
Actinium Pharmaceuticals’s (7AY1) 100-Day exponential moving average is 0.93, while Actinium Pharmaceuticals’s (7AY1) share price is €0.86, making it a Buy.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.86 and Actinium Pharmaceuticals’s (7AY1) 50-day simple moving average is 0.91, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.86 and Actinium Pharmaceuticals’s (7AY1) 100-day simple moving average is 0.88, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.86 and Actinium Pharmaceuticals’s (7AY1) 200-day simple moving average is 0.94, creating a Sell signal.

Actinium Pharmaceuticals (7AY1) Technical Indicators

Oct 12, 2026, 05:13 AM
Name
Value
Implied Action
RSI (14)
45.06
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
15.73
Buy
Williams %R
-100.00
Buy
CCI (14)
-148.84
Buy
ATR (14)
0.03
-
Ultimate Oscillator
39.37
Neutral
ROC
-9.88
Sell
Actinium Pharmaceuticals’s (7AY1) Relative Strength Index (RSI) is 45.06, creating a Neutral signal.
Actinium Pharmaceuticals’s (7AY1) Trend Strength Indicator (ADX) is 15.73, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) Commodity Channel Index (CCI) is -148.84, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) Price Rate of Change (ROC) is -9.88, creating a Sell signal.

FAQ

Is 7AY1 a Buy, Hold, or Sell?
Based on 7AY1’s technical indicators, 7AY1 is a Hold.
    What is 7AY1’s RSI (14)?
    7AY1’s RSI (14) is 45.06, which suggests 7AY1 is a Neutral.
      What is 7AY1’s MACD?
      7AY1’s MACD is <0.01, which suggests 7AY1 is a Buy.
        What is 7AY1’s 5-day moving average?
        7AY1’s 5-day moving average is 0.98, which suggests 7AY1 is a Sell.
          What is 7AY1’s 20-day moving average?
          7AY1 20-day moving average is 1.02, which suggests 7AY1 is a Sell.
            What is 7AY1’s 50-day moving average?
            7AY1’s 50-day moving average is 0.91, which suggests 7AY1 is a Buy.
              What is 7AY1’s 200-day moving average?
              7AY1’s 200-day moving average is 0.94, which suggests 7AY1 is a Sell.
                What is 7AY1’s Williams % R (14)?
                7AY1’s Williams % R (14) is -100.00, which suggests 7AY1 is a Buy.
                  What is 7AY1’s CCI (14)?
                  7AY1’s CCI (14) is -148.84, which suggests 7AY1 is a Buy.
                    What is the share price of Actinium Pharmaceuticals?